Heartflow (NASDAQ:HTFL) CFO Sells $230,752.32 in Stock

Posted by Geri Gentry on Sep 15th, 2026

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) CFO Vikram Verghese sold 4,593 shares of the company’s stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $50.24, for a total transaction of $230,752.32. Following the completion of the transaction, the chief financial officer owned 180,196 shares of the company’s stock, valued at approximately $9,053,047.04. The trade was a 2.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

On Tuesday, September 15th, Vikram Verghese sold 668 shares of Heartflow stock. The stock was sold at an average price of $50.01, for a total value of $33,406.68.
On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The shares were sold at an average price of $50.06, for a total value of $1,487,482.84.
On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The stock was sold at an average price of $50.03, for a total value of $332,199.20.
On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The stock was sold at an average price of $49.69, for a total value of $1,368,462.60.
On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The shares were sold at an average price of $50.60, for a total transaction of $297,325.60.

Heartflow Stock Down 2.4%

Shares of Heartflow stock traded down $1.21 during midday trading on Tuesday, hitting $48.33. The company had a trading volume of 2,031,448 shares, compared to its average volume of 1,972,264. Heartflow, Inc. has a 12-month low of $20.13 and a 12-month high of $51.78. The stock has a market cap of $4.20 billion and a price-to-earnings ratio of -26.41. The company has a fifty day simple moving average of $36.39 and a 200 day simple moving average of $31.21.

Heartflow (NASDAQ:HTFL – Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The company had revenue of $64.08 million for the quarter. The firm’s quarterly revenue was up 47.7% on a year-over-year basis. As a group, analysts expect that Heartflow, Inc. will post -0.75 EPS for the current year.

Hedge Funds Weigh In On Heartflow

A number of hedge funds have recently made changes to their positions in the business. XXEC Inc. purchased a new position in Heartflow in the second quarter valued at about $2,524,764,000. BlackRock Inc. purchased a new stake in shares of Heartflow in the second quarter worth about $152,502,000. Bamco Inc. NY purchased a new position in Heartflow in the 2nd quarter worth approximately $94,625,000. Jupiter Topco LLC acquired a new stake in Heartflow in the second quarter valued at approximately $70,983,000. Finally, Janus Henderson Group PLC raised its stake in shares of Heartflow by 152.0% during the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after purchasing an additional 1,315,416 shares during the period.

Trending Headlines about Heartflow

Here are the key news stories impacting Heartflow this week:

Positive Sentiment: Heartflow’s latest quarterly results showed strong operating momentum: revenue rose 47.7% year over year to $64.08 million, while its $0.07-per-share loss was narrower than analysts expected. Heartflow stock and earnings information
Positive Sentiment: Several institutions recently initiated or increased positions, including Squarepoint Ops, which lifted its stake by 72%, providing a potential source of buying support.
Positive Sentiment: Analyst sentiment remains broadly favorable, with a consensus “Moderate Buy” rating. UBS set a $55 price target, above the recent trading range, while other firms maintained Buy or Overweight ratings.
Neutral Sentiment: The CFO’s sales were disclosed as part of a planned trading program, reducing the likelihood that the transactions represent a new negative view of Heartflow’s business. After selling 35,?—actually 35,? shares across September 11–15, CFO Vikram Verghese still owned roughly 179,528 shares.
Negative Sentiment: CFO Vikram Verghese sold a combined 34,975 shares for approximately $1.75 million at prices near $50 per share, reducing his direct ownership by roughly 16.7% over the reported transactions. CFO SEC filing
Negative Sentiment: CEO John Farquhar also sold 38,900 shares for approximately $1.82 million on September 10–11 and has reported multiple sales since June. The repeated selling by senior executives, particularly after the stock approached its 52-week high, is likely contributing to short-term pressure. HeartFlow CEO share sale

Analysts Set New Price Targets

Several research analysts have weighed in on HTFL shares. Canaccord Genuity Group increased their target price on shares of Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. Benchmark reaffirmed a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. Freedom Capital upgraded shares of Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. Stifel Nicolaus lifted their price target on Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research report on Friday, August 14th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Heartflow currently has a consensus rating of “Moderate Buy” and an average target price of $44.88.

Check Out Our Latest Analysis on HTFL

About Heartflow

(Get Free Report)

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).